ID   AAKB1_RAT               Reviewed;         270 AA.
AC   P80386; Q63048;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   24-JUL-2024, entry version 200.
DE   RecName: Full=5'-AMP-activated protein kinase subunit beta-1;
DE            Short=AMPK subunit beta-1;
DE            Short=AMPKb;
DE   AltName: Full=5'-AMP-activated protein kinase 40 kDa subunit;
GN   Name=Prkab1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8621499; DOI=10.1074/jbc.271.15.8675;
RA   Gao G., Fernandez C.S., Stapleton D., Auster A.S., Widmer J., Dyck J.R.B.,
RA   Kemp B.E., Witters L.A.;
RT   "Non-catalytic beta- and gamma-subunit isoforms of the 5'-AMP-activated
RT   protein kinase.";
RL   J. Biol. Chem. 271:8675-8681(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar;
RX   PubMed=8626596; DOI=10.1074/jbc.271.17.10282;
RA   Woods A., Cheung P.C.F., Smith F.C., Davison M.D., Scott J., Beri R.K.,
RA   Carling D.;
RT   "Characterization of AMP-activated protein kinase beta and gamma subunits.
RT   Assembly of the heterotrimeric complex in vitro.";
RL   J. Biol. Chem. 271:10282-10290(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-159, AND PROTEIN SEQUENCE OF 36-72; 79-83
RP   AND 90-159.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=7961907; DOI=10.1016/s0021-9258(18)43879-3;
RA   Stapleton D., Gao G., Michell B.J., Widmer J., Mitchelhill K.I., Teh T.,
RA   House C.M., Witters L.A., Kemp B.E.;
RT   "Mammalian 5'-AMP-activated protein kinase non-catalytic subunits are
RT   homologs of proteins that interact with yeast Snf1 protein kinase.";
RL   J. Biol. Chem. 269:29343-29346(1994).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE, MYRISTOYLATION AT GLY-2, AND PHOSPHORYLATION AT
RP   SER-24; SER-25; SER-108 AND SER-182.
RX   PubMed=9305909; DOI=10.1074/jbc.272.39.24475;
RA   Mitchelhill K.I., Michell B.J., House C.M., Stapleton D., Dyck J.,
RA   Gamble J., Ullrich C., Witters L.A., Kemp B.E.;
RT   "Posttranslational modifications of the 5'-AMP-activated protein kinase
RT   beta1 subunit.";
RL   J. Biol. Chem. 272:24475-24479(1997).
RN   [6]
RP   MUTAGENESIS, MYRISTOYLATION AT GLY-2, AND PHOSPHORYLATION AT SER-24;
RP   SER-25; SER-108 AND SER-182.
RX   PubMed=11171104; DOI=10.1042/0264-6021:3540275;
RA   Warden S.M., Richardson C., O'Donnell J. Jr., Stapleton D., Kemp B.E.,
RA   Witters L.A.;
RT   "Post-translational modifications of the beta-1 subunit of AMP-activated
RT   protein kinase affect enzyme activity and cellular localization.";
RL   Biochem. J. 354:275-283(2001).
RN   [7]
RP   PHOSPHORYLATION AT SER-96; SER-101 AND SER-108.
RX   PubMed=12764152; DOI=10.1074/jbc.m303946200;
RA   Woods A., Vertommen D., Neumann D., Turk R., Bayliss J., Schlattner U.,
RA   Wallimann T., Carling D., Rider M.H.;
RT   "Identification of phosphorylation sites in AMP-activated protein kinase
RT   (AMPK) for upstream AMPK kinases and study of their roles by site-directed
RT   mutagenesis.";
RL   J. Biol. Chem. 278:28434-28442(2003).
RN   [8]
RP   PHOSPHORYLATION BY ULK1.
RX   PubMed=21460634; DOI=10.4161/auto.7.7.15451;
RA   Loffler A.S., Alers S., Dieterle A.M., Keppeler H., Franz-Wachtel M.,
RA   Kundu M., Campbell D.G., Wesselborg S., Alessi D.R., Stork B.;
RT   "Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory
RT   feedback loop.";
RL   Autophagy 7:696-706(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40 AND SER-108, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.49 ANGSTROMS) OF 68-162 IN COMPLEX WITH
RP   BETA-CYCLODEXTRIN, DOMAIN GLYCOGEN-BINDING, AND MUTAGENESIS OF TRP-100;
RP   LYS-126; LEU-146 AND ASN-150.
RX   PubMed=16216577; DOI=10.1016/j.str.2005.07.008;
RA   Polekhina G., Gupta A., van Denderen B.J., Feil S.C., Kemp B.E.,
RA   Stapleton D., Parker M.W.;
RT   "Structural basis for glycogen recognition by AMP-activated protein
RT   kinase.";
RL   Structure 13:1453-1462(2005).
CC   -!- FUNCTION: Non-catalytic subunit of AMP-activated protein kinase (AMPK),
CC       an energy sensor protein kinase that plays a key role in regulating
CC       cellular energy metabolism. In response to reduction of intracellular
CC       ATP levels, AMPK activates energy-producing pathways and inhibits
CC       energy-consuming processes: inhibits protein, carbohydrate and lipid
CC       biosynthesis, as well as cell growth and proliferation. AMPK acts via
CC       direct phosphorylation of metabolic enzymes, and by longer-term effects
CC       via phosphorylation of transcription regulators. Also acts as a
CC       regulator of cellular polarity by remodeling the actin cytoskeleton;
CC       probably by indirectly activating myosin. Beta non-catalytic subunit
CC       acts as a scaffold on which the AMPK complex assembles, via its C-
CC       terminus that bridges alpha (PRKAA1 or PRKAA2) and gamma subunits
CC       (PRKAG1, PRKAG2 or PRKAG3).
CC   -!- SUBUNIT: AMPK is a heterotrimer of an alpha catalytic subunit (PRKAA1
CC       or PRKAA2), a beta (PRKAB1 or PRKAB2) and a gamma non-catalytic
CC       subunits (PRKAG1, PRKAG2 or PRKAG3). Interacts with FNIP1 and FNIP2.
CC       {ECO:0000269|PubMed:16216577}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney, heart, white adipose
CC       tissue, lung and spleen.
CC   -!- DOMAIN: The glycogen-binding domain may target AMPK to glycogen so that
CC       other factors like glycogen-bound debranching enzyme or protein
CC       phosphatases can directly affect AMPK activity.
CC       {ECO:0000269|PubMed:16216577}.
CC   -!- PTM: Phosphorylated when associated with the catalytic subunit (PRKAA1
CC       or PRKAA2). Phosphorylated by ULK1; leading to negatively regulate AMPK
CC       activity and suggesting the existence of a regulatory feedback loop
CC       between ULK1 and AMPK. {ECO:0000269|PubMed:11171104,
CC       ECO:0000269|PubMed:12764152, ECO:0000269|PubMed:21460634,
CC       ECO:0000269|PubMed:9305909}.
CC   -!- SIMILARITY: Belongs to the 5'-AMP-activated protein kinase beta subunit
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U42411; AAC52579.1; -; mRNA.
DR   EMBL; BC062008; AAH62008.1; -; mRNA.
DR   EMBL; X95577; CAA64830.1; -; mRNA.
DR   RefSeq; NP_114182.1; NM_031976.1.
DR   RefSeq; XP_006249543.1; XM_006249481.3.
DR   PDB; 1Z0M; X-ray; 1.91 A; A/B/C=68-163.
DR   PDB; 1Z0N; X-ray; 1.49 A; A/B/C=68-163.
DR   PDB; 4EAG; X-ray; 2.70 A; B=187-270.
DR   PDB; 4EAK; X-ray; 2.50 A; B=200-270.
DR   PDB; 4EAL; X-ray; 2.51 A; B=200-270.
DR   PDB; 4QFG; X-ray; 3.46 A; B=68-270.
DR   PDB; 4QFR; X-ray; 3.34 A; B=68-270.
DR   PDB; 4QFS; X-ray; 3.55 A; B=68-270.
DR   PDB; 4YEF; X-ray; 1.72 A; A/B/C/D/E/F/G=76-156.
DR   PDB; 5KQ5; X-ray; 3.41 A; B=68-270.
DR   PDB; 5T5T; X-ray; 3.46 A; B=68-270.
DR   PDB; 5UFU; X-ray; 3.45 A; B=67-270.
DR   PDB; 6E4T; X-ray; 3.40 A; B=67-270.
DR   PDB; 6E4U; X-ray; 3.27 A; B=67-270.
DR   PDB; 6E4W; X-ray; 3.35 A; B=67-270.
DR   PDBsum; 1Z0M; -.
DR   PDBsum; 1Z0N; -.
DR   PDBsum; 4EAG; -.
DR   PDBsum; 4EAK; -.
DR   PDBsum; 4EAL; -.
DR   PDBsum; 4QFG; -.
DR   PDBsum; 4QFR; -.
DR   PDBsum; 4QFS; -.
DR   PDBsum; 4YEF; -.
DR   PDBsum; 5KQ5; -.
DR   PDBsum; 5T5T; -.
DR   PDBsum; 5UFU; -.
DR   PDBsum; 6E4T; -.
DR   PDBsum; 6E4U; -.
DR   PDBsum; 6E4W; -.
DR   AlphaFoldDB; P80386; -.
DR   SMR; P80386; -.
DR   BioGRID; 249839; 243.
DR   DIP; DIP-59127N; -.
DR   IntAct; P80386; 177.
DR   STRING; 10116.ENSRNOP00000001508; -.
DR   BindingDB; P80386; -.
DR   ChEMBL; CHEMBL5054; -.
DR   CAZy; CBM48; Carbohydrate-Binding Module Family 48.
DR   iPTMnet; P80386; -.
DR   PhosphoSitePlus; P80386; -.
DR   jPOST; P80386; -.
DR   PaxDb; 10116-ENSRNOP00000001508; -.
DR   DNASU; 83803; -.
DR   Ensembl; ENSRNOT00000001508.4; ENSRNOP00000001508.1; ENSRNOG00000001142.4.
DR   Ensembl; ENSRNOT00055003507; ENSRNOP00055002613; ENSRNOG00055002209.
DR   Ensembl; ENSRNOT00060010651; ENSRNOP00060007895; ENSRNOG00060006496.
DR   Ensembl; ENSRNOT00065002773; ENSRNOP00065001907; ENSRNOG00065002107.
DR   Ensembl; ENSRNOT00065008546; ENSRNOP00065006028; ENSRNOG00065005719.
DR   GeneID; 83803; -.
DR   KEGG; rno:83803; -.
DR   UCSC; RGD:71057; rat.
DR   AGR; RGD:71057; -.
DR   CTD; 5564; -.
DR   RGD; 71057; Prkab1.
DR   eggNOG; KOG1616; Eukaryota.
DR   GeneTree; ENSGT00940000155307; -.
DR   HOGENOM; CLU_070949_2_0_1; -.
DR   InParanoid; P80386; -.
DR   OMA; QPTVFRW; -.
DR   OrthoDB; 120305at2759; -.
DR   PhylomeDB; P80386; -.
DR   TreeFam; TF313827; -.
DR   BRENDA; 2.7.11.31; 5301.
DR   Reactome; R-RNO-1632852; Macroautophagy.
DR   Reactome; R-RNO-380972; Energy dependent regulation of mTOR by LKB1-AMPK.
DR   Reactome; R-RNO-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-RNO-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   EvolutionaryTrace; P80386; -.
DR   PRO; PR:P80386; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000001142; Expressed in heart and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031588; C:nucleotide-activated protein kinase complex; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0031669; P:cellular response to nutrient levels; ISO:RGD.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0035878; P:nail development; ISO:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   CDD; cd02859; E_set_AMPKbeta_like_N; 1.
DR   Gene3D; 6.20.250.60; -; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR032640; AMPK1_CBM.
DR   InterPro; IPR006828; ASC_dom.
DR   InterPro; IPR037256; ASC_dom_sf.
DR   InterPro; IPR050827; CRP1_MDG1_kinase.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   PANTHER; PTHR10343; 5'-AMP-ACTIVATED PROTEIN KINASE , BETA SUBUNIT; 1.
DR   PANTHER; PTHR10343:SF96; 5'-AMP-ACTIVATED PROTEIN KINASE SUBUNIT BETA-1; 1.
DR   Pfam; PF16561; AMPK1_CBM; 1.
DR   Pfam; PF04739; AMPKBI; 1.
DR   SMART; SM01010; AMPKBI; 1.
DR   SUPFAM; SSF160219; AMPKBI-like; 1.
DR   SUPFAM; SSF81296; E set domains; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Lipid biosynthesis; Lipid metabolism; Lipoprotein;
KW   Myristate; Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..270
FT                   /note="5'-AMP-activated protein kinase subunit beta-1"
FT                   /id="PRO_0000204367"
FT   REGION          1..43
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          68..163
FT                   /note="Glycogen-binding domain"
FT   COMPBIAS        11..43
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         4
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y478"
FT   MOD_RES         5
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y478"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y478"
FT   MOD_RES         19
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y478"
FT   MOD_RES         24
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:11171104,
FT                   ECO:0000269|PubMed:9305909"
FT   MOD_RES         25
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:11171104,
FT                   ECO:0000269|PubMed:9305909"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         96
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:12764152"
FT   MOD_RES         101
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:12764152"
FT   MOD_RES         108
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:11171104,
FT                   ECO:0000269|PubMed:12764152, ECO:0000269|PubMed:9305909,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         148
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y478"
FT   MOD_RES         182
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:11171104,
FT                   ECO:0000269|PubMed:9305909"
FT   MOD_RES         201
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R078"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000269|PubMed:11171104,
FT                   ECO:0000269|PubMed:9305909"
FT   MUTAGEN         100
FT                   /note="W->G: Abolishes glycogen-binding."
FT                   /evidence="ECO:0000269|PubMed:16216577"
FT   MUTAGEN         100
FT                   /note="W->L: Partially inhibits glycogen-binding."
FT                   /evidence="ECO:0000269|PubMed:16216577"
FT   MUTAGEN         126
FT                   /note="K->Q: Abolishes glycogen-binding."
FT                   /evidence="ECO:0000269|PubMed:16216577"
FT   MUTAGEN         146
FT                   /note="L->A: Significantly reduces glycogen-binding."
FT                   /evidence="ECO:0000269|PubMed:16216577"
FT   MUTAGEN         150
FT                   /note="N->K: Abolishes glycogen-binding."
FT                   /evidence="ECO:0000269|PubMed:16216577"
FT   MUTAGEN         150
FT                   /note="N->Q: Significantly reduces glycogen-binding."
FT                   /evidence="ECO:0000269|PubMed:16216577"
FT   CONFLICT        26
FT                   /note="G -> E (in Ref. 1; AAC52579)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        52
FT                   /note="M -> I (in Ref. 4; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          78..84
FT                   /evidence="ECO:0007829|PDB:1Z0N"
FT   STRAND          91..95
FT                   /evidence="ECO:0007829|PDB:1Z0N"
FT   HELIX           96..98
FT                   /evidence="ECO:0007829|PDB:1Z0N"
FT   STRAND          102..104
FT                   /evidence="ECO:0007829|PDB:4YEF"
FT   STRAND          106..108
FT                   /evidence="ECO:0007829|PDB:1Z0N"
FT   STRAND          111..118
FT                   /evidence="ECO:0007829|PDB:1Z0N"
FT   STRAND          120..129
FT                   /evidence="ECO:0007829|PDB:1Z0N"
FT   STRAND          132..134
FT                   /evidence="ECO:0007829|PDB:1Z0N"
FT   STRAND          141..143
FT                   /evidence="ECO:0007829|PDB:1Z0N"
FT   STRAND          149..155
FT                   /evidence="ECO:0007829|PDB:1Z0N"
FT   HELIX           157..159
FT                   /evidence="ECO:0007829|PDB:6E4U"
FT   STRAND          161..163
FT                   /evidence="ECO:0007829|PDB:1Z0N"
FT   HELIX           164..170
FT                   /evidence="ECO:0007829|PDB:4QFG"
FT   HELIX           208..211
FT                   /evidence="ECO:0007829|PDB:6E4U"
FT   TURN            214..216
FT                   /evidence="ECO:0007829|PDB:6E4U"
FT   STRAND          225..227
FT                   /evidence="ECO:0007829|PDB:6E4U"
FT   HELIX           233..235
FT                   /evidence="ECO:0007829|PDB:6E4U"
FT   STRAND          240..245
FT                   /evidence="ECO:0007829|PDB:4EAL"
FT   STRAND          248..257
FT                   /evidence="ECO:0007829|PDB:4EAK"
FT   STRAND          260..269
FT                   /evidence="ECO:0007829|PDB:4EAK"
SQ   SEQUENCE   270 AA;  30394 MW;  62726DD357F36C7C CRC64;
     MGNTSSERAA LERQAGHKTP RRDSSGGTKD GDRPKILMDS PEDADIFHTE EMKAPEKEEF
     LAWQHDLEVN EKAPAQARPT VFRWTGGGKE VYLSGSFNNW SKLPLTRSQN NFVAILDLPE
     GEHQYKFFVD GQWTHDPSEP IVTSQLGTVN NIIQVKKTDF EVFDALMVDS QKCSDVSELS
     SSPPGPYHQE PYISKPEERF KAPPILPPHL LQVILNKDTG ISCDPALLPE PNHVMLNHLY
     ALSIKDGVMV LSATHRYKKK YVTTLLYKPI
//
